The Assessment of Single-Dose Safety,Tolerability, Pharmacokinetics and Pharmacodynamic of Globalagliatin Hydrochloride
Status:
Completed
Trial end date:
2018-01-09
Target enrollment:
Participant gender:
Summary
This is a phase 1 randomized,double-blind,placebo-controlled study with single oral dose of
globalagliatin hydrochloride (SY-004) administered to chinese healthy subjects to evaluated
the safety, tolerability, pharmacokinetics and pharmacodynamics of globalagliatin
hydrochloride (SY-004).